It has been suggested that chylomicrons or their remnants are atherogenic. Our goal is to develop and apply a test which can measure chylomicron and chylomicron remnant clearance to see if abnormalities in this process correlate with fasting lipoprotein abnormalities associated with premature atherosclerosis.
Showing the most recent 10 out of 461 publications